ENGINEERING OF AVERMECTIN PKS GENES TO IMPROVE IVERMECTIN PRODUCTION IN STREPTOMYCES AVERMITILIS

来源 :15th International Symposiium on the Biology of Actinomycete | 被引量 : 0次 | 上传用户:haorui524
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Ivermectin,22,23-dihydroavermectin B I.are used worldwide in livestock production and in health care of animals.It is currently synthesized by chemical reduction of the double bond between C22 and C23 of avermectin B 1 produced by Streptomyces avermitilis using rhodium chloride as a special catalyst for region-specific hydrogenation[1].This process is expensive,and causes heavy metal pollution.
其他文献
会议
会议
Thousands of halogenated natural products have been isolated from terrestrial organisms.These natural products include important antibiotics such as vancomycin,chloramphenicol and rebeccamycin.Marine
会议
会议
会议
会议
Streptomyces sp.139 producted a novel exopolysaccharide (EPS) designated as Ebosin,which has antagonist activity for IL-IR in vitro and remarkable anti-rheumatic arthritis activity in vivo.The biosynt
会议
Rapamycin is one of triene macrolide antibiotics.It is used in clinics as a potent immunosuppressant with antifungal and antitumor activities.Studies on rapamycin biosynthesis (rap) and genetics have
会议
A novel DNA sulfur modification was discovered [1],and it has been identified as a phosphorothioate modification which is the first known physiological modification of DNAs backbone [2-4].In vitro the
会议